Connexins in endothelial cells as a therapeutic target for solid organ transplantation

Dinesh Jaishankar, Kristen M. Quinn, Jes Sanders, Leah Plumblee, Thomas A. Morinelli, Satish N. Nadig*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Connexins are a class of membrane proteins widely distributed throughout the body and have various functions based on their location and levels of expression. More specifically, connexin proteins expressed in endothelial cells (ECs) have unique roles in maintaining EC barrier integrity and function—a highly regulated process that is critical for pro-inflammatory and pro-coagulant reactions. In this minireview, we discuss the regulatory influence connexin proteins have in maintaining EC barrier integrity and their role in ischemia–reperfusion injury as it relates to organ transplantation. It is evident that certain isoforms of the connexin protein family are uniquely positioned to have far-reaching effects on preserving organ function; however, there is still much to be learned of their roles in transplant immunology and the application of this knowledge to the development of targeted therapeutics.

Original languageEnglish (US)
Pages (from-to)2502-2508
Number of pages7
JournalAmerican Journal of Transplantation
Volume22
Issue number11
DOIs
StatePublished - Nov 2022

Funding

This study was supported by the National Institute of Health (NIAID R01 AI142079) awarded to Dr. Satish N. Nadig.

Keywords

  • basic (laboratory) research/science
  • cellular biology
  • ischemia reperfusion injury (IRI)
  • organ perfusion and preservation
  • solid organ transplantation
  • translational research/science

ASJC Scopus subject areas

  • Transplantation
  • Pharmacology (medical)
  • Immunology and Allergy

Fingerprint

Dive into the research topics of 'Connexins in endothelial cells as a therapeutic target for solid organ transplantation'. Together they form a unique fingerprint.

Cite this